A double-blind randomized controlled trial of low doses of propranolol, nortriptyline, and the combination of propranolol and nortriptyline for the preventive treatment of migraine

Arquivos de Neuro-Psiquiatria

Volumn 67, Issue 4, 2009, Pages 973-977

  Domingues, Renan B ^a,b   Pirajá Da Silva, André L ^a   Domingues, Simone A ^a   Aquino, Camila Catherine H ^a   Kuster, Gustavo W ^a  

^a Escola Superior de Ciencias da Santa Casa de Misericordia de Vitoria   (Brazil)

^b FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

Author keywords

Combined therapy; Migraine; Nortryptiline; Propranolol

Indexed keywords

NORTRIPTYLINE; PROPRANOLOL;

ADULT; AGE DISTRIBUTION; ARTICLE; CLINICAL TRIAL; CONSTIPATION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; DIZZINESS; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; FEMALE; HEADACHE; HUMAN; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; PROPHYLAXIS; RANDOMIZED CONTROLLED TRIAL; SEX RATIO; SIDE EFFECT; SOMNOLENCE; TRANSFORMED MIGRAINE; TREATMENT DURATION; WEIGHT GAIN; XEROSTOMIA;

EID: 76149088462     PISSN: 0004282X     EISSN: 16784227     Source Type: Journal    
DOI: 10.1590/S0004-282X2009000600002     Document Type: Article

References (18)

1. Lipton RB, Stewart WF, Diamond S, et al. Prevalence and burden o migraine in the United States: data from the American Migraine Study II. Headache 2001;41:646-657.
2. Queiroz LP, Peres MFP, Kowacs F, et al. Um estudo epidemiológico nacional da cefaléia no Brasil. Migrâneas Cefaléias 2008;11:190-196.
3. Bigal ME, Rapoport AM, Bordini CA, et al. Burden of migraine in Brazil: estimate of cost of migraine to the public health system and an analytical study of the cost-effectiveness of a stratified model of care. Headache 2003;43:742-754.
4. Massiou H. Prophylactic treatments of migraine. Rev Neurol (Paris) 2000;156(Suppl 4):S79-S86.
5. Ramadan NM. Current trends in migraine prophylaxis. Headache 2007; 47(Suppl 1):S52-S57.
6. Linde K, Rossnagel K. Propranolol for migraine prophylaxis. Cochrane Database Syst Rev 2004:CD003225.
7. Tvedskov JF, Thomsen LL, Thomsen LL, et al. The effect of propranolol on glyceryltrinitrate-induced headache and arterial response. Cephalalgia 2004;24:1076-1087.
8. Pradalier A, Serratrice G, Collard M, et al. Long-acting propranolol in migraine prophylaxis: results of a double-blind, placebo-controlled study. Cephalalgia 1989;9:247-253.
9. al-Qassab HK, Findley LJ. Comparison of propranolol LA 80 mg and propranolol LA 160 mg in migraine prophylaxis: a placebo controlled study. Cephalalgia 1993;13:128-131.
10. Punay NC, Couch JR. Antidepressants in the treatment of migraine headache. Curr Pain Headache Rep 2003;7:51-54.
11. Bordini CA, Arruda MA, Ciciarelli MC, Speciali JG. Propranolol vs flunarizine vs flunarizine plus propranolol in migraine without aura prophylaxis: a double-blind trial. Arq Neuropsiquiatr 1997;55:536-341.
12. Kaniecki RG. A comparison of divalproex with propranolol and placebo for the prophylaxis of migraine without aura. Arch Neurol 1997;54:1141-1145.
13. Keskinbora K, Aydinli I. A double-blind randomized controlled trial of topiramate and amitriptyline either alone or in combination for the prevention of migraine. Clin Neurol Neurosurg 2008;110:979-984.
14. Peterlin BL, Calhoun AH, Siegel S, Mathew NT. Rational combination therapy in refractory migraine. Headache 2008;48:805-819.
15. Headache Classification Subcomitte of the International Headache Society. The Internacional Classification of Headache Disorders. 2nd Edition. Cephalalgia 2004;24:1-160.
16. Bigal ME, Serrano D, Reed M, Lipton RB. Chronic migraine in the population: burden, diagnosis, and satisfaction with treatment. Neurology 2008;71:559-566.
17. Seok JI, Cho HI, Chung CS. From transformed migraine to episodic migraine: reversion factors. Headache 2006;46:1186-1190.
18. Taylor FR. Weight change associated with the use of migraine-preventive medications. Clin Ther 2008;30:1069-1080.